Coherus Oncology, Inc. (CHRS) vs Canton Strategic Holdings Inc (CNTN)
A side-by-side comparison of Coherus Oncology, Inc. and Canton Strategic Holdings Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CHRS
Coherus Oncology, Inc.
$1.12HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CNTN
Canton Strategic Holdings Inc
$2.33HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CHRS vs CNTN
growth of $100 · dividends reinvested · last 5yCHRS -92.2% (-39.9%/yr)CNTN -99.8% (-71.8%/yr)CHRS compounded faster over this window
Log scale — wide-divergence pair
CHRS CNTN
CHRS vs CNTN: by the numbers
- •CNTN is the larger company ($180M vs $173M market cap).
- •Both run net losses; CHRS's is the smaller (-257.10% vs -6559.27% net margin).
Metrics side by side
Valuation
| Metric | CHRS | CNTN |
|---|---|---|
| P/S ratio | 3.40 | 120.13 |
| P/B ratio | 2.84 | 0.40 |
Profitability
| Metric | CHRS | CNTN |
|---|---|---|
| Gross margin | 63.55% | 0.00% |
| Operating margin | -425.72% | 0.00% |
| Net margin | -257.10% | -6559.27% |
| ROE | -215.26% | -21.57% |
| ROIC | -135.38% | -9.57% |
Growth (annualized)
| Metric | CHRS | CNTN |
|---|---|---|
| Revenue CAGR (5Y) | -33.60% | N/A |
| Total return CAGR (5Y) | -41.38% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.